Fuclav Tablet 125 mg+31.25 mg contains a combination of Cefuroxime Axetil and Clavulanic Acid, a synergistic antibiotic formulation used to treat a broad spectrum of bacterial infections. Cefuroxime Axetil is a second-generation cephalosporin that inhibits bacterial cell wall synthesis, leading to the destruction of susceptible bacteria. Clavulanic Acid is a beta-lactamase inhibitor that protects cefuroxime from enzymatic degradation by beta-lactamase-producing bacteria, enhancing its effectiveness against resistant strains.

This combination ensures a potent antibacterial effect, making Fuclav ideal for treating infections caused by both Gram-positive and Gram-negative bacteria. Its oral tablet form allows convenient dosing for adults and children, making it suitable for outpatient therapy.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Indications

Fuclav Tablet 125 mg+31.25 mg is indicated for the treatment of:

• Respiratory tract infections, including sinusitis, bronchitis, and pneumonia

• Ear, nose, and throat infections, such as otitis media and tonsillitis

• Skin and soft tissue infections, including cellulitis and wound infections

• Urinary tract infections

• Prophylaxis in surgical procedures to prevent postoperative bacterial infections

• Other infections caused by susceptible bacteria, especially beta-lactamase-producing strains

The combination is effective against Staphylococcus aureus, Streptococcus species, Haemophilus influenzae, Escherichia coli, and other common pathogens.

Dosage and Administration

The recommended dosage of Fuclav Tablet 125 mg+31.25 mg depends on the severity of infection, age, and body weight:

• Adults and children over 12 years: Typically, 1 tablet every 8–12 hours, or as directed by a physician

• Pediatric patients: Dose calculated according to body weight and severity of infection

• Swallow the tablet whole with water; it can be taken with or without food

• Maintain consistent dosing at regular intervals for optimum effect

• Complete the full course of therapy even if symptoms improve early to prevent recurrence and bacterial resistance

Benefits

• Broad-spectrum antibacterial activity against both Gram-positive and Gram-negative bacteria

• Beta-lactamase inhibition enhances efficacy against resistant bacterial strains

• Effective in treating a wide range of infections, including respiratory, ENT, skin, and urinary tract infections

• Convenient oral tablet for outpatient therapy

• Reduces the risk of complications by eradicating infection efficiently

Side Effects

Fuclav Tablet 125 mg+31.25 mg is generally well tolerated, though mild side effects may include:

• Nausea, vomiting, or diarrhea

• Abdominal discomfort or bloating

• Rash, itching, or mild allergic reactions

• Headache or dizziness

Rare but serious side effects may include severe allergic reactions, liver toxicity, or Clostridium difficile-associated diarrhea. Patients should seek immediate medical attention if they experience severe rash, swelling, difficulty breathing, or persistent diarrhea.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Precautions

• Avoid in patients with a known allergy to cephalosporins, penicillins, or beta-lactam antibiotics

• Use cautiously in patients with kidney or liver impairment; dose adjustment may be required

• Inform your doctor of all medications and supplements being taken to avoid drug interactions

• Pregnant and breastfeeding women should use only under medical supervision

• Monitor for signs of superinfection during prolonged therapy

Storage

Store below 30°C in a dry place, protected from light and moisture. Keep out of reach of children.

Fuclav Tablet 125 mg+31.25 mg (Cefuroxime Axetil + Clavulanic Acid) is an effective oral antibiotic for treating a wide range of bacterial infections, providing enhanced protection against resistant bacteria and ensuring rapid recovery under proper medical supervision.